Monday, October 7, 2024
SRI spin-off company, Arrayus, announces Health Canada approval of its focused ultrasound therapy system
Arrayus Technologies Inc., a SRI spin-off company, is pleased to announce that its MRI-guided FUS system has been granted approval by Health Canada for the ablation of uterine fibroid tissue.
Monday, September 23, 2024
StrokeGoRed awarded $5M towards improving stroke care, treatment and recovery for women
A Sunnybrook-led group of researchers championing women’s brain health has been awarded $5 million in funding over five years to investigate the diagnosis and treatment of stroke in women through the StrokeGoRed project.
Friday, September 20, 2024
Drug that lowers blood sugar prevents hospitalization and death in heart failure; when given early
A new study shows that patients with diabetes who started a blood-sugar-regulating drug soon after hospital discharge for acute heart failure had better results than those who received the drug later.
Thursday, September 19, 2024
Populations with modifiable risk factors for dementia identified
A new study pinpoints three sub-groups of individuals in their early 60’s who have an observable risk for dementia that they and their clinicians can still do something about.
Monday, September 16, 2024
The future of non-invasive focused ultrasound therapies
In an article published in the September 13, 2024 issue of the journal Science, SRI scientist and Canada Research Chair Dr. Meaghan O’Reilly provides an overview of the roots of FUS, its advances, and future outlook; highlighting four areas that have seen growth and sustained research interest in non-thermal therapeutic applications of the technology in and outside the brain.
